Stepanov commented on the suspension of the use of the AstraZeneca vaccine in European countries



[ad_1]

To date, there is not a single confirmation of the connection between coronavirus vaccination with the drug AstraZeneca and the appearance of blood clots in patients, stressed the Minister of Health of Ukraine, Maxim Stepanov. According to him, in Ukraine there have been no cases of thrombosis after receiving the vaccine.

Conclusions on the link between vaccination against coronavirus infection with the AstraZeneca drug and the formation of blood clots in patients can be drawn after the completion of studies conducted by the World Health Organization and the European Agency for Medicines.

This opinion was expressed by the Minister of Health of Ukraine, Maxim Stepanov, on the air of the channel “Ukraine 24”.

“To date, no country has been established in the world and there is not a single confirmation of the relationship between vaccination and thrombosis. There are relevant studies, including those carried out by the European regulator in charge of pharmacovigilance and the WHO. no confirmation yet. 37 thromboses were detected for every 17 million vaccinated people, that is, one thrombosis for every 460-470 thousand inhabitants. If we compare what happens in everyday life, we understand that there may be people who may have thrombosis regardless of vaccination. . I think we should wait for medical research to be done and draw conclusions, “he said.

Uses of Ukraine a licensed vaccine developed in India by AstraZeneca called Covishield.

Stepanov pointed out that since the beginning of the vaccination, more than 62 thousand people have been vaccinated in the country. According to the minister, 0.5% of them reported side effects, but none developed blood clots.

“We have not recorded any thrombosis. With regard to the world’s leading countries, for example, the British regulator, which is the world’s strictest regulator, has already clearly stated that they are not going to suspend the vaccination of AstraZeneca, which they do not have. confirmation of the link between vaccination and thrombosis. Canada said the same thing. I think European countries will say the same in the near future. If we talk about the benefits and risks, the benefits of vaccination far outweigh any reactions and side effects “added the minister.

More than 10 countries announced in recent days the suspension of the use of the AstraZeneca coronavirus vaccine or its individual batches. In particular, in Denmark cases of thrombosis have been reported in patients who received the vaccine. Other states have stated that no such cases have been recorded, but they are suspending vaccination with this drug as a precautionary measure.

At the World Health Organization and the European Medicines Agency (EMA) reported that the association between AstraZeneca vaccination and the incidence of thrombosis has not been confirmed and that the benefits of the vaccine outweigh the risks. The developer stated that their studies found no evidence of an increased risk of thrombosis among those vaccinated.

In January, the UK was the first in the world to start mass vaccination with AstraZeneca. The Stiko Vaccination Standing Committee at the Robert Koch Institute for Virology in Germany recommended on January 28 the use of the AstraZeneca vaccine for citizens aged 18 to 64 years.

On January 29, the EMA authorized the use of AstraZeneca’s COVID-19 vaccine in the European Union. On the same day, the European Commission approved delivery of the vaccine to the EU.

The agency noted that clinical studies of the AstraZeneca coronavirus vaccine have shown it to be effective in preventing COVID-19 in people over the age of 18. The efficacy of the vaccine is set at around 60%.



[ad_2]